Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Addressing operational risk and variability in the clinical development process can reduce cycle times by more than six months on average and shave around 30% off the cost of clinical trials, argues a ...
This is not the current manual. From January 2015, guidelines were developed using Developing NICE guidelines: the manual. The National Institute for Health and Clinical Excellence (NICE) is the ...
Over the past decade, a shift has been occurring in biopharma R&D. Despite great advancements in drug technologies and our understanding of diseases, it is getting harder to develop new drugs and ...
RESEARCH TRIANGLE PARK, N.C., July 14, 2025--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics ...
The message underpinning the WHO’s latest European Health Report could not have been clearer: Europe must confront its soaring chronic disease rates. With one quarter of the European working ...
New York – Oct. 23, 2025 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and Sanofi today announced an expansion of their ...
Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...
Site Name: UK – Cambridgeshire – AddenbrookesIn this role you will be responsible for leading a cross functional GSK Clinical Unit Cambridge study team in the delivery of quality multiple clinical ...
2.2.1 Topics are referred to NICE by the Department of Health or the NHS Commissioning Board. The criteria for the referral to NICE should include both suitability for a short clinical guideline and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback